Alimera Sciences CEO and leadership

Rick joined Alimera Sciences in 2005 as CFO and assumed the position of COO in 2010. He is responsible for strategic finance, accounting, distribution logistics, human resources and information technology. Rick brings a wealth of financial and operational management experience with both public and private ventures to the team. Since joining Alimera, he completed three rounds of venture funding totaling approximately $67 million. In 2010 Rick led Alimera's successful IPO, raising $72 million, and negotiated a $32.5 million credit facility leading to recognition of Alimera as the \'Strategic Deal of the Year\' by both Southeastern BIO and Georgia BIO.

Rick currently serves as the chairman of the board of directors and audit committee of Jones Soda Co., a Seattle-based publicly traded company, and vice-chairman of the North Metro Miracle League, an Atlanta-based charitable organization.

Rick has been active in Atlanta business for more than 20 years, with experience that includes financial and accounting management, mergers and acquisitions, and initial public offerings, as well as entrepreneurial and start-up operational activities. Rick is the founder of two consulting practices, Brand Ignition Group and Black River Holdings, Inc. He is also the former chief financial officer and senior executive vice president of Netzee, Inc., a provider of internet banking solutions to community banks that went public in 1999. Rick started his career in Arthur Andersen’s audit and business advisory practice where he was a senior manager and a certified public accountant. He has an accounting degree from Wake Forest University.

David Holland is one of our co-founders and has served as our Chief Marketing Officer, Senior Vice President Corporate Communications and Managed Markets since January 2, 2019. Prior to this, he was Senior Vice President U.S. Sales and Marketing from August 2010 through December 2018. Mr. Holland was the Vice President of Marketing since the founding of our Company in 2003 through August 2010. Prior to founding our Company, Mr. Holland served as the Vice President of Marketing of Novartis Ophthalmics from 1998 to 2003. In 1997, Mr. Holland served as Global Head of the Lens Business at CIBA Vision and in 1996, Global Head of the Lens Care Business of CIBA Vision. From 1992 to 1995, Mr. Holland served as the Director of Marketing for CIBA Vision Ophthalmics. From 1989 to 1991, Mr. Holland served as New Products Manager for CIBA Vision. From 1985 to 1989, Mr. Holland served as a Brand Assistant and Assistant Brand Manager of Procter and Gamble. Mr. Holland holds an A.B. in Politics from Princeton University.

Phil Jones is a CFO at ALIMERA SCIENCES INC and is based in Greater Atlanta Area. He has worked as Director Of Accounting at Superior Essex; Staff Accountant at O'Neal & Saul, CPA; and Controller at Arjo Wiggins Medical. J attended Auburn University.

Philip Ashman, Ph.D. joined Alimera Sciences in January 2013 as Senior Vice President and European Managing Director and leads the company’s European operations, Alimera Sciences Limited, headquartered in the United Kingdom. In this role, he oversees the expansion of the Alimera brand, management of the commercial launch of ILUVIEN®, as well as development of our European growth strategy. Philip has more than 20 years of experience in all aspects of pharmaceutical management. Most recently, he was responsible for leadership of the market access strategy in the U.K. for Bayer, covering all therapy areas including ophthalmology. Also while at Bayer, he held numerous leadership roles, including serving as vice president responsible for setting strategy and early preparations for specialty medicines. He also served as Bayer Regional Business Unit Head (Europe) in Oncology, responsible for the delivery of oncology sales and profitability targets in Europe, Canada, the Middle East and Africa. Philip holds a doctorate in biochemistry from the University of London: Royal Holloway and Bedford, U.K., and a Bachelor of Science degree in biochemistry from the University College London, U.K.

David Holland is one of our co-founders and has served as our Chief Marketing Officer, Senior Vice President Corporate Communications and Managed Markets since January 2, 2019. Prior to this, he was Senior Vice President U.S. Sales and Marketing from August 2010 through December 2018. Mr. Holland was the Vice President of Marketing since the founding of our Company in 2003 through August 2010. Prior to founding our Company, Mr. Holland served as the Vice President of Marketing of Novartis Ophthalmics from 1998 to 2003. In 1997, Mr. Holland served as Global Head of the Lens Business at CIBA Vision and in 1996, Global Head of the Lens Care Business of CIBA Vision. From 1992 to 1995, Mr. Holland served as the Director of Marketing for CIBA Vision Ophthalmics. From 1989 to 1991, Mr. Holland served as New Products Manager for CIBA Vision. From 1985 to 1989, Mr. Holland served as a Brand Assistant and Assistant Brand Manager of Procter and Gamble. Mr. Holland holds an A.B. in Politics from Princeton University.

Rick joined Alimera Sciences in 2005 as CFO and assumed the position of COO in 2010. He is responsible for strategic finance, accounting, distribution logistics, human resources and information technology. Rick brings a wealth of financial and operational management experience with both public and private ventures to the team. Since joining Alimera, he completed three rounds of venture funding totaling approximately $67 million. In 2010 Rick led Alimera's successful IPO, raising $72 million, and negotiated a $32.5 million credit facility leading to recognition of Alimera as the \'Strategic Deal of the Year\' by both Southeastern BIO and Georgia BIO.

Rick currently serves as the chairman of the board of directors and audit committee of Jones Soda Co., a Seattle-based publicly traded company, and vice-chairman of the North Metro Miracle League, an Atlanta-based charitable organization.

Rick has been active in Atlanta business for more than 20 years, with experience that includes financial and accounting management, mergers and acquisitions, and initial public offerings, as well as entrepreneurial and start-up operational activities. Rick is the founder of two consulting practices, Brand Ignition Group and Black River Holdings, Inc. He is also the former chief financial officer and senior executive vice president of Netzee, Inc., a provider of internet banking solutions to community banks that went public in 1999. Rick started his career in Arthur Andersen’s audit and business advisory practice where he was a senior manager and a certified public accountant. He has an accounting degree from Wake Forest University.

David Holland is one of our co-founders and has served as our Chief Marketing Officer, Senior Vice President Corporate Communications and Managed Markets since January 2, 2019. Prior to this, he was Senior Vice President U.S. Sales and Marketing from August 2010 through December 2018. Mr. Holland was the Vice President of Marketing since the founding of our Company in 2003 through August 2010. Prior to founding our Company, Mr. Holland served as the Vice President of Marketing of Novartis Ophthalmics from 1998 to 2003. In 1997, Mr. Holland served as Global Head of the Lens Business at CIBA Vision and in 1996, Global Head of the Lens Care Business of CIBA Vision. From 1992 to 1995, Mr. Holland served as the Director of Marketing for CIBA Vision Ophthalmics. From 1989 to 1991, Mr. Holland served as New Products Manager for CIBA Vision. From 1985 to 1989, Mr. Holland served as a Brand Assistant and Assistant Brand Manager of Procter and Gamble. Mr. Holland holds an A.B. in Politics from Princeton University.

Phil Jones is a CFO at ALIMERA SCIENCES INC and is based in Greater Atlanta Area. He has worked as Director Of Accounting at Superior Essex; Staff Accountant at O'Neal & Saul, CPA; and Controller at Arjo Wiggins Medical. J attended Auburn University.

Philip Ashman, Ph.D. joined Alimera Sciences in January 2013 as Senior Vice President and European Managing Director and leads the company’s European operations, Alimera Sciences Limited, headquartered in the United Kingdom. In this role, he oversees the expansion of the Alimera brand, management of the commercial launch of ILUVIEN®, as well as development of our European growth strategy. Philip has more than 20 years of experience in all aspects of pharmaceutical management. Most recently, he was responsible for leadership of the market access strategy in the U.K. for Bayer, covering all therapy areas including ophthalmology. Also while at Bayer, he held numerous leadership roles, including serving as vice president responsible for setting strategy and early preparations for specialty medicines. He also served as Bayer Regional Business Unit Head (Europe) in Oncology, responsible for the delivery of oncology sales and profitability targets in Europe, Canada, the Middle East and Africa. Philip holds a doctorate in biochemistry from the University of London: Royal Holloway and Bedford, U.K., and a Bachelor of Science degree in biochemistry from the University College London, U.K.